|
⚲
|
| Keyboard |
| Brenda Gavin | |
|---|---|
| Firm | |
| Address | c/o Quaker BioVentures Cira Center, 2929 Arch Street, Suite 325 Philadelphia, PA 19104 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Tetralogic Pharmaceuticals Corp | 021-188311 | Director | 5.0 M of 10.0 M |
||
| Tetralogic Pharmaceuticals Corp | 021-160530 | Director | 6.0 M of 6.0 M |
||
| Tengion Inc | 021-156826 | Director | 31.4 M of 31.4 M |
||
| Celator Pharmaceuticals Inc | 021-147373 | Director | 15.0 M of 20.0 M |
||
| Tetralogic Pharmaceuticals Corp | 021-146152 | Director | 12.5 M of 32.0 M |
||
| Tranzyme Inc | 021-143976 | Director | 2.0 M of 3.0 M |
||
| Celator Pharmaceuticals Inc | 021-141795 | Director | 2.5 M of 2.5 M |
||
| Tetralogic Pharmaceuticals Corp | 021-89076 | Director | 2.0 M of 2.0 M |
||
| Bioleap Inc | 021-137695 | Director | 5.0 M | ||
| Diasome Pharmaceuticals LLC | 021-108333 | Director | 12.9 M of 13.4 M |
||